deutsch
english
francais
italiano
espanol
Photo
KEYCODE BAYER 564

Wednesday, October 16

Baycol case: New life for whistleblower

The U.S. 8th Circuit Court of Appeals resuscitated a whistleblower’s lawsuit that claims Bayer Healthcare made fraudulent claims to induce the Department of Defense to buy its cholesterol-reducing drug, Baycol. Earlier, the suit was dismissed by a federal judge who concluded that the suit’s claims regarding sales of Baycol to Medicare and Medicaid were lodged after a six-year statute of limitations had expired.

full text of the court´s decision

more information:
=> Whistleblower Lawsuit Filed Over Baycol Fraud
=> NY Times: Bayer Knew of Dangers of Its Cholesterol Drug
=> Argentina: BAYER Sentenced To Pay Compensation
=> LIPOBAY: CONDENA MILLONARIA CONTRA BAYER EN ARGENTINA
=> US Supreme Court allows cholesterol drug suit
=> Bayer Held Back on Drug Dangers